1
|
Jujic A, Vieira JPP, Matuskova H, Nilsson PM, Lindblad U, Olsen MH, Duarte JMN, Meissner A, Magnusson M. Plasma Galectin-4 Levels Are Increased after Stroke in Mice and Humans. Int J Mol Sci 2023; 24:10064. [PMID: 37373212 DOI: 10.3390/ijms241210064] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Revised: 05/08/2023] [Accepted: 05/19/2023] [Indexed: 06/29/2023] Open
Abstract
Epidemiological studies have associated plasma galectin-4 (Gal-4) levels with prevalent and incident diabetes, and with an increased risk of coronary artery disease. To date, data regarding possible associations between plasma Gal-4 and stroke are lacking. Using linear and logistic regression analyses, we tested Gal-4 association with prevalent stroke in a population-based cohort. Additionally, in mice fed a high-fat diet (HFD), we investigated whether plasma Gal-4 increases in response to ischemic stroke. Plasma Gal-4 was higher in subjects with prevalent ischemic stroke, and was associated with prevalent ischemic stroke (odds ratio 1.52; 95% confidence interval 1.01-2.30; p = 0.048) adjusted for age, sex, and covariates of cardiometabolic health. Plasma Gal-4 increased after experimental stroke in both controls and HFD-fed mice. HFD exposure was devoid of impact on Gal-4 levels. This study demonstrates higher plasma Gal-4 levels in both experimental stroke and in humans that experienced ischemic stroke.
Collapse
Affiliation(s)
- Amra Jujic
- Wallenberg Centre for Molecular Medicine, Lund University, 22100 Lund, Sweden
- Department of Clinical Sciences, Lund University, 20502 Malmö, Sweden
- Department of Cardiology, Skåne University Hospital, 21428 Malmö, Sweden
| | - João P P Vieira
- Wallenberg Centre for Molecular Medicine, Lund University, 22100 Lund, Sweden
- Department of Experimental Medical Science, Lund University, 22100 Lund, Sweden
| | - Hana Matuskova
- Wallenberg Centre for Molecular Medicine, Lund University, 22100 Lund, Sweden
- Department of Experimental Medical Science, Lund University, 22100 Lund, Sweden
- German Center for Neurodegenerative Diseases, 53127 Bonn, Germany
| | - Peter M Nilsson
- Department of Clinical Sciences, Lund University, 20502 Malmö, Sweden
| | - Ulf Lindblad
- General Practice-Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden
| | - Michael H Olsen
- Department of Internal Medicine 1, Holbaek Hospital, 4300 Holbaek, Denmark
- Department of Regional Health Research, University of Southern Denmark, 5000 Odense, Denmark
| | - João M N Duarte
- Wallenberg Centre for Molecular Medicine, Lund University, 22100 Lund, Sweden
- Department of Experimental Medical Science, Lund University, 22100 Lund, Sweden
| | - Anja Meissner
- Wallenberg Centre for Molecular Medicine, Lund University, 22100 Lund, Sweden
- Department of Experimental Medical Science, Lund University, 22100 Lund, Sweden
- German Center for Neurodegenerative Diseases, 53127 Bonn, Germany
- Department of Physiology, Institute for Theoretical Medicine, University of Augsburg, 86159 Augsburg, Germany
| | - Martin Magnusson
- Wallenberg Centre for Molecular Medicine, Lund University, 22100 Lund, Sweden
- Department of Clinical Sciences, Lund University, 20502 Malmö, Sweden
- Department of Cardiology, Skåne University Hospital, 21428 Malmö, Sweden
- Hypertension in Africa Research Team (HART), North-West University, Potchefstroom 2520, South Africa
| |
Collapse
|